CommentThe use of inhaled corticosteroids in early-stage COVID-19
References (7)
- et al.
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: a randomized clinical trial
EClinicalMedicine
(2021) - et al.
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Lancet Respir Med
(2021) - et al.
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
Lancet Respir Med
(2020)
There are more references available in the full text version of this article.
Cited by (2)
© 2021 Elsevier Ltd. All rights reserved.